Christopher Thor

Christopher Thor is a seasoned Biomarker Scientist with extensive experience in hematologic and solid tumor malignancies. They have planned and executed four phase 1 programs and have contributed impactful late-stage biomarker data analysis for pivotal phase 2 studies. Current roles include Senior Scientist at Seattle Genetics and a forthcoming position as Senior Scientist at Pfizer, where they lead biomarker programs in various cancer indications. Christopher's academic background includes a Bachelor of Science in Molecular Biology from Washington State University and a Master's degree in Pharmaceutical Bioengineering from the University of Washington. Outside the lab, Christopher is an avid skier, white-water rafter, and outdoor enthusiast.